Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiyo Pharmaceutical Industry Co. Ltd.

Division of Teva Pharmaceutical Industries Ltd.
www.taiyo-yakuhin.com

Latest From Taiyo Pharmaceutical Industry Co. Ltd.

Chugai Explores New Tech In Strategic Push For Innovation

Chugai is investing in new R&D infrastructure and exploring disruptive technologies as part of a strategic push to build its global drug discovery capabilities.

Research and Development Strategies Biologics

Asia Executives To Watch: Chugai New CEO, Sawai, RDPAC, Bayhelix

Roche’s Japan subsidiary, Chugai, will have a new CEO next year while RDPAC in China has appointed new executive members.

Appointments Asia Pacific

Distortion And Inflation In Measuring Pharma M&A

Five companies in big pharma’s top 20 have come through mergers in the past 10 years or so that changed them significantly. As measured by standard financial performance parameters, the processes at Takeda and Teva (and to some extent, at Allergan) seem relatively smooth and productive. Those at Pfizer and Merck don’t. But it depends on how you look at the numbers.

Deals Business Strategies

Teva JV Allows Takeda To Offload Mature Japan Portfolio

Takeda is to transfer the bulk of its mature products in Japan into a new joint venture with Teva, in a move that will allow the Japanese firm to focus on its innovative portfolio while boosting the Israeli generic giant’s reach in Japan's fast-growing generics sector.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Makoto Shimada, Pres. & CEO
  • Contact Info
  • Taiyo Pharmaceutical Industry Co. Ltd.
    Phone: (0)52-459-5001
    24-11 Taikou 1-chome
    Nakamura-ku
    Nagoya-city, Aichi, 453-0801
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register